Logo     Print Page  Close Window


News, Events & Presentations


Press Releases | Events Calendar | Presentations

Keyword Search
 
2018 | 2017 | 2016 | 2015
DateTitle 
02/06/18Fibrocell to Present at 20th Annual BIO CEO & Investor ConferencePrinter Friendly Version
02/05/18Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized SclerodermaPrinter Friendly Version
01/30/18Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Printer Friendly Version
01/24/18Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018 Printer Friendly Version